MiNK Therapeutics's total assets for Q4 2024 were $5.72M, a decrease of -22.43% from the previous quarter. INKT total liabilities were $25.31M for the fiscal quarter, a 1.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.